Kura Oncology Inc (NASDAQ: KURA) established initial surge of 4.47% at $17.78, before settling in for the price of $17.02 at the close. Taking a more long-term approach, KURA posted a 52-week range of $7.41-$24.17.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was -3.94%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -17.20%. This publicly-traded company’s shares outstanding now amounts to $74.35 million, simultaneously with a float of $64.93 million. The organization now has a market capitalization sitting at $1.36 billion. At the time of writing, stock’s 50-day Moving Average stood at $19.35, while the 200-day Moving Average is $20.06.
Kura Oncology Inc (KURA) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Kura Oncology Inc industry. Kura Oncology Inc’s current insider ownership accounts for 15.28%, in contrast to 91.08% institutional ownership. According to the most recent insider trade that took place on May 20 ’24, this organization’s Chief Legal Officer sold 2,615 shares at the rate of 22.15, making the entire transaction reach 57,916 in total value, affecting insider ownership by 68,979. Preceding that transaction, on Jan 29 ’24, Company’s SVP, Finance & Accounting sold 2,318 for 17.80, making the whole transaction’s value amount to 41,262. This particular insider is now the holder of 48,093 in total.
Kura Oncology Inc (KURA) Earnings and Revenue Records
Kura Oncology Inc’s EPS decrease for this current 12-month fiscal period is -17.20% and is forecasted to reach -2.62 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 19.93% through the next 5 years, which can be compared against the -3.94% growth it accomplished over the previous five years trading on the market.
Kura Oncology Inc (NASDAQ: KURA) Trading Performance Indicators
Let’s observe the current performance indicators for Kura Oncology Inc (KURA). It’s Quick Ratio in the last reported quarter now stands at 14.94. The Stock has managed to achieve an average true range (ATR) of 0.66.
In the same vein, KURA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.23, a figure that is expected to reach -0.63 in the next quarter, and analysts are predicting that it will be -2.62 at the market close of one year from today.
Technical Analysis of Kura Oncology Inc (KURA)
Now, what If we examine the latest scores posted by [Kura Oncology Inc, KURA]. During the last 5-days, its volume was lower the volume of 0.9 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 19.65% While, its Average True Range was 0.65.
Raw Stochastic average of Kura Oncology Inc (KURA) in the period of the previous 100 days is set at 12.44%, which indicates a major fall in contrast to 43.67% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 29.03% that was lower than 37.52% volatility it exhibited in the past 100-days period.
